Related Experiment Video

Updated: Jul 14, 2026

Anti-Nuclear Antibody Screening Using HEp-2 Cells
13:01

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

The use of anthrax antigen to immunise man and monkey

F C BELTON, H M DARLOW, D W HENDERSON

    Lancet (London, England)
    |September 8, 1956
    PubMed
    Abstract

    No abstract available in PubMed .

    Keywords:
    ANTHRAX/immunology

    More Related Videos

    Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
    07:10

    Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

    Published on: January 7, 2019

    Generation and Functional Verification of Hypoxia-Sensitive Chimeric Antigen Receptor-T Cells
    09:12

    Generation and Functional Verification of Hypoxia-Sensitive Chimeric Antigen Receptor-T Cells

    Published on: June 14, 2024

    Related Experiment Videos

    Last Updated: Jul 14, 2026

    Anti-Nuclear Antibody Screening Using HEp-2 Cells
    13:01

    Anti-Nuclear Antibody Screening Using HEp-2 Cells

    Published on: June 23, 2014

    Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
    07:10

    Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

    Published on: January 7, 2019

    Generation and Functional Verification of Hypoxia-Sensitive Chimeric Antigen Receptor-T Cells
    09:12

    Generation and Functional Verification of Hypoxia-Sensitive Chimeric Antigen Receptor-T Cells

    Published on: June 14, 2024

    Related Concept Videos

    Diphtheria01:28

    Diphtheria

    Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
    Respiratory Syncytial Virus Disease01:29

    Respiratory Syncytial Virus Disease

    Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...

    Articles linked to this work by shared authors, journal, and citation graph.

    Facts and fiction: premalignant lesions of lung tissues.

    Pathology·2013

    1-Methylguanosine in place of Y base at position 37 in phenylalanine tRNA is responsible for its shiftiness in retroviral ribosomal frameshifting.

    Virology·2001

    Chromosomal and extrachromosomal instability of the cyclin D2 gene is induced by Myc overexpression.

    Neoplasia (New York, N.Y.)·2000

    The ribonucleotide reductase R2 gene is a non-transcribed target of c-Myc-induced genomic instability.

    Gene·1999

    Reactive mesothelial hyperplasia vs mesothelioma, including mesothelioma in situ: a brief review.

    American journal of clinical pathology·1998

    Activation of bcl-2 suppressible 40 and 44 kDa p38-like kinases during apoptosis of early and late B lymphocytic cell lines.

    FEBS letters·1998

    Catheter ablation for symptomatic atrial fibrillation (PVI-SHAM-AF): a randomised, double-blind, sham-controlled, multicentre trial.

    Lancet (London, England)·2026

    Cardiovascular disease in pregnancy: physiology, global burden, risk stratification, and opportunities in care.

    Lancet (London, England)·2026

    Aetiology, management, and outcomes of acute heart failure in 17 African countries (THESUS-HF II): a prospective, multicentre, observational cohort study.

    Lancet (London, England)·2026

    Adverse pregnancy outcomes and long-term cardiovascular disease risk.

    Lancet (London, England)·2026

    Discontinuation of β-blockers in stable patients with previous myocardial infarction, preserved left ventricular ejection fraction, and no heart failure: a pooled analysis of individual patient data.

    Lancet (London, England)·2026

    Safety and efficacy of the 0/1 h pathway for myocardial infarction in the emergency department: an international, pragmatic, stepped-wedge, cluster-randomised, controlled trial.

    Lancet (London, England)·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us